The finding that cysteamine and cystamine synergized when administered in combination with capreomycin and most importantly with amikacin in primary human macrophages infected with Mtb and in the GLS ex vivo model of infection further highlights the potential usefulness of these two anti-TG2 inhibitors as HDTs against TB. Here, TGM2 is linked to infection.